Olmesartan medoxomil 40 MG tab 90S
Ended Awarded
- Contract number
- SPE2DB26FHVUK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,227
Award facts
- Contract value 100% obligated
- $9,227.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Olmesartan Medoxomil 40 mg tablets (90-count) with a ceiling value of $9,227.35. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive SPE2DX contract vehicle enables the supply of a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This delivery order for Olmesartan Medoxomil represents routine pharmaceutical procurement under that global pharmaceutical support vehicle, consistent with the company's extensive track record fulfilling federal medical supply needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FHVUK?
SPE2DB26FHVUK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FHVUK worth?
The government has obligated $9,227 on SPE2DB26FHVUK.
Is contract SPE2DB26FHVUK an order under another contract?
Yes. SPE2DB26FHVUK is a delivery order under SPE2DB24D2109, an indefinite delivery contract.
Was contract SPE2DB26FHVUK competed?
The extent of competition for SPE2DB26FHVUK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award